Pfizer Inc. (PFE) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Pfizer Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$29.45
−1.17% today
Market cap
$169.9B
Overall quality
—
Kronos AI 30-day
−13.4%
0 of 8 simulated paths end higher
Pfizer Inc. (PFE) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $169.9B. It trades at $29.45, down 1.17% today. 22 analysts' average target of $29.62 implies +0.6% from today's price. Kronos AI's 30-day forecast is −13.4% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $29.62 |
| Low – high | $25.00 – $36.00 |
| Analysts | 22 |
| Upside to average | +0.6% |
Kronos AI 30-day forecast
| Expected close | $25.99 (−13.4%) |
| Likely range | −17.1% … −11.9% |
| As of | 2026-10-26 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Does not pass |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.